Literature DB >> 22527577

Aneurysm treatment in Europe 2010: an internet survey.

Ondrej Bradac1, Susie Hide, David A Mendelow, Vladimir Benes.   

Abstract

BACKGROUND: Aneurysm (AN) treatment appears to differ from country to country and even from centre to centre. Therefore we decided to conduct a survey in order to better understand the "state of the art" in aneurysm treatment in Europe. The primary aim was to understand the roles of clipping and coiling in aneurysm treatment.
METHODS: An interactive form was sent to major European neurosurgical centres. The responses relating to AN location, status (ruptured/unruptured) and treatment modality were divided with regard to the volume of cases and the centre's geographical location.
RESULTS: Responses were received from 96 European centres. The main finding was that clipping was used significantly more often in Eastern Europe than in the rest of Europe to treat ruptured ANs of the anterior circulation. Almost all ruptured ANs across all locations are treated actively. The treatment of unruptured aneurysms of the anterior circulation is similar. The median relating to observed unruptured ANs across the Europe was 10 %. Posterior circulation ANs are treated predominantly by coiling, regardless of aneurysm status or geographical location. The average number of coilers versus surgeons per centre was 2.5:3.0 in Western, 1.9:3.6 in Southern, 1.9:4.3 in Eastern and 2.7:3.1 in Northern Europe.
CONCLUSIONS: The way in which intracranial aneurysms are treated appears to correlate with the economic development of European countries. It is probably also affected by the lack of experienced coilers in Eastern Europe.

Entities:  

Mesh:

Year:  2012        PMID: 22527577     DOI: 10.1007/s00701-012-1340-2

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

Review 1.  "Coil mainly" policy in management of intracranial ACoA aneurysms: single-centre experience with the systematic review of literature and meta-analysis.

Authors:  Anna Steklacova; Ondrej Bradac; Patricia de Lacy; Jiri Lacman; Frantisek Charvat; Vladimir Benes
Journal:  Neurosurg Rev       Date:  2017-11-28       Impact factor: 3.042

2.  Outcome for unruptured middle cerebral artery aneurysm treatment: surgical and endovascular approach in a single center.

Authors:  Philipp Dammann; Tobias Schoemberg; Oliver Müller; Neriman Özkan; Marc Schlamann; Isabel Wanke; I Erol Sandalcioglu; Michael Forsting; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2014-07-09       Impact factor: 3.042

3.  Aneurismal subarachnoid hemorrhage: who remains for surgical treatment in the post-ISAT era?

Authors:  Marta Koźba-Gosztyła; Bogdan Czapiga; Włodzimierz Jarmundowicz
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

4.  Effect of weekend admission on in-hospital mortality and functional outcomes for patients with acute subarachnoid haemorrhage (SAH).

Authors:  Harshal Deshmukh; Matthew Hinkley; Louise Dulhanty; Hiren C Patel; J P Galea
Journal:  Acta Neurochir (Wien)       Date:  2016-03-01       Impact factor: 2.216

5.  Treatment Outcomes with Selective Coil Embolization for Large or Giant Aneurysms : Prognostic Implications of Incomplete Occlusion.

Authors:  Kyung Il Jo; Na-Rae Yang; Pyoung Jeon; Keon Ha Kim; Seung-Chyul Hong; Jong Soo Kim
Journal:  J Korean Neurosurg Soc       Date:  2017-12-29

6.  International Subarachnoid Aneurysm Trial - ISAT part II: study protocol for a randomized controlled trial.

Authors:  Tim E Darsaut; Andrew S Jack; Richard S Kerr; Jean Raymond
Journal:  Trials       Date:  2013-05-29       Impact factor: 2.279

7.  Four-year trends in the treatment of cerebral aneurysms in Poland in 2009-2012.

Authors:  Tomasz Tykocki; Kacper Kostyra; Marcin Czyż; Bogusław Kostkiewicz
Journal:  Acta Neurochir (Wien)       Date:  2014-02-06       Impact factor: 2.216

8.  Extended endoscopic endonasal approaches for cerebral aneurysms: anatomical, virtual reality and morphometric study.

Authors:  Alberto Di Somma; Matteo de Notaris; Vita Stagno; Luis Serra; Joaquim Enseñat; Isam Alobid; Joan San Molina; Joan Berenguer; Paolo Cappabianca; Alberto Prats-Galino
Journal:  Biomed Res Int       Date:  2014-01-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.